Novartis deal caps Alteogen’s banner year as ALT-B4 moves into commercial era Korea Biomedical Review 5d
STAT Plus: Novartis’ experimental cardiovascular drug fails a pivotal study STAT 3d Pharma Drugs and Alcohol Biotech
Novartis strikes $3.2 billion deal with Alteogen as drug delivery patent licences pile up IAM 4d Pharma
What data says about Tukaram Mundhe’s 100-day stint as FDA Commissioner The Hindu 3h FDA India Article paywall
Watson-Marlow to showcase fluid management solutions at European events European Pharmaceutical Manufacturer 15h
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore The Hindu Business Line 1d Novartis Pfizer India
AstraZeneca's breast cancer drug granted accelerated approval in the US ShareCast 1d AstraZeneca FDA FTSE 100 Article paywall
